276 related articles for article (PubMed ID: 7544068)
21. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
[TBL] [Abstract][Full Text] [Related]
22. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA
Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
[TBL] [Abstract][Full Text] [Related]
23. Down syndrome and neural tube defect screening: the value of using gestational age by ultrasonography.
Benn PA; Borgida A; Horne D; Briganti S; Collins R; Rodis JF
Am J Obstet Gynecol; 1997 May; 176(5):1056-61. PubMed ID: 9166168
[TBL] [Abstract][Full Text] [Related]
24. The comprehensive midtrimester test: high-sensitivity Down syndrome test.
Bahado-Singh R; Shahabi S; Karaca M; Mahoney MJ; Cole L; Oz UA
Am J Obstet Gynecol; 2002 Apr; 186(4):803-8. PubMed ID: 11967511
[TBL] [Abstract][Full Text] [Related]
25. Prospective evaluation of prenatal maternal serum screening for trisomy 18.
Yankowitz J; Fulton A; Williamson R; Grant SS; Budelier WT
Am J Obstet Gynecol; 1998 Mar; 178(3):446-50. PubMed ID: 9539506
[TBL] [Abstract][Full Text] [Related]
26. An artificial intelligent diagnostic system with neural networks to determine genetical disorders and fetal health by using maternal serum markers.
Beksaç MS; Durak B; Ozkan O; Cakar AN; Balci S; Karakaş U; Laleli Y
Eur J Obstet Gynecol Reprod Biol; 1995 Apr; 59(2):131-6. PubMed ID: 7544745
[TBL] [Abstract][Full Text] [Related]
27. Detection of fetal Turner syndrome with multiple-marker screening.
Wenstrom KD; Williamson RA; Grant SS
Am J Obstet Gynecol; 1994 Feb; 170(2):570-3. PubMed ID: 7509569
[TBL] [Abstract][Full Text] [Related]
28. [Noninvasive serum test for prenatal detection of Down syndrome, other chromosome abnormalities and open neural tube defects--a prospective study].
Zwahr C; Voss P; Kistner G
Geburtshilfe Frauenheilkd; 1994 Jun; 54(6):355-61. PubMed ID: 7522195
[TBL] [Abstract][Full Text] [Related]
29. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
Dick PT
CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
[TBL] [Abstract][Full Text] [Related]
30. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
[TBL] [Abstract][Full Text] [Related]
31. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
32. The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity.
Huderer-Duric K; Skrablin S; Kuvacic I; Sonicki Z; Rubala D; Suchanek E
Eur J Obstet Gynecol Reprod Biol; 2000 Jan; 88(1):49-55. PubMed ID: 10659916
[TBL] [Abstract][Full Text] [Related]
33. Normal nuchal thickness in the midtrimester indicates reduced risk of Down syndrome in pregnancies with abnormal triple-screen results.
Bahado-Singh RO; Goldstein I; Uerpairojkit B; Copel JA; Mahoney MJ; Baumgarten A
Am J Obstet Gynecol; 1995 Oct; 173(4):1106-10. PubMed ID: 7485301
[TBL] [Abstract][Full Text] [Related]
34. Risk of abnormal triple screen for Down syndrome is significantly higher in patients with female fetuses.
Spong CY; Ghidini A; Stanley-Christian H; Meck JM; Seydel FD; Pezzullo JC
Prenat Diagn; 1999 Apr; 19(4):337-9. PubMed ID: 10327139
[TBL] [Abstract][Full Text] [Related]
35. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
36. [Detection of chromosomal abnormalities using cordocentesis].
Zolotukhina TV; Kuznetsov MI; Kostiuk EV; Shilova NV; Solonichenko VG
Genetika; 1991 Aug; 27(8):1481-5. PubMed ID: 1722186
[TBL] [Abstract][Full Text] [Related]
37. Adverse perinatal outcome in patients screen-positive for neural tube defects and fetal Down syndrome.
Gross SJ; Phillips OP; Shulman LP; Bright NL; Dungan JS; Simpson JL; Elias S
Prenat Diagn; 1994 Jul; 14(7):609-13. PubMed ID: 7526367
[TBL] [Abstract][Full Text] [Related]
38. [Prenatal diagnosis of trisomy 21].
Massé J; Forest JC
Ann Biol Clin (Paris); 1990; 48(8):536-40. PubMed ID: 1705107
[TBL] [Abstract][Full Text] [Related]
39. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
Benn PA; Ying J; Beazoglou T; Egan JF
Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
[TBL] [Abstract][Full Text] [Related]
40. Down syndrome: prenatal risk assessment and diagnosis.
Newberger DS
Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
